Edukasi Vaksinasi Covid-19 dan Peningkatan Daya Tahan Tubuh melalui Suplemen Kesehatan

Siti Maimunah, Yen Yen Ari Indrawijaya, Prida Ayudianti, Yuliono Trika Nur Hasan

Abstract


At the end of 2019, a corona virus known as Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) was discovered and spread rapidly, resulting in a global pandemic. In February 2020, the World Health Organization (WHO) defined the disease as COVID-19, which stands for Coronavirus Disease 2019. When the immune system or immune system does not function properly, the body will experience a disease that can cause death. Having a good immune system is an effort to deal with COVID-19. Vaccines to prevent SARS-CoV-2 infection are considered to be the most promising approach to curb the pandemic and are being pursued vigorously. Development of Standardized Herbal Medicines and Phytopharmaceuticals in Indonesia, in addition to promoting and protecting the use of native Indonesian medicinal plants, is also for the realization of measures in the community in dealing with controlling the spread of COVID-19 in Indonesia. This service aims to be able to determine the level of knowledge about vaccines, maintaining immunity, and public health supplements around the Faculty of Medicine and Health Sciences, especially Krajan Hamlet, Sumbersekar Village, Dau Regency which is located 9.3 KM from campus III. The measurement of the level of knowledge was carried out by filling out the pretest and posttest by the respondents.

Full Text:

PDF

References


World Health Organization. Director-General's remarks at the media briefing on 2019- nCoV on 11 February 2020. http://www.who.int/dg/speeches/detail/who- director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11- february-2020 (Accessed on February 12, 2020).

World Health Organization. Draft landscape of COVID-19 candidate vaccines. https://www.wh o.int/publications/m/item/draft-landscape-of-covid-19- candidate-vaccines (Accessed on Octob er 20, 2020).

College of Physicians of Philadelphia. The History of Vaccines: Vaccine Development, Testing, and Regulation. https://www.historyofvaccines.org/content/articles/vaccine-development-testing-and-regulation (Accessed on October 20, 2020).

Brighton Collaboration. Accelerated Assessment of the Risk of Disease Enhancement with COVID-19 Vaccines, March 2020. https://brightoncollaboration.us/brighton-collaboration-cepi-covid-19-web-conference/ (Accessed on October 20, 2020).

US Food and Drug Administration. Development and Licensure of Vaccines to Prevent COVID-19: Guidance for Industry.https://www.fda.gov/media/139638/download (Accessed on Octobe r 20, 2020). WHO Target Product Profiles for COVID-19 Vaccines. April 2020. https://www.who.int/publicati ons/m/item/who-target-product-profiles-for- covid-19-vaccines (Accessed on November 06, 20 20).

Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010; 17:1055. US Food and Drug Administration. Emergency Use Authorization for Vaccines to Prevent COV ID-19: Guidance for Industry. October 2020. https://www.fda.gov/media/142749/download (Ac cessed on November 05, 2020).

US Department of Health and Human Services. Fact Sheet: Explaining Operation Warp Speed. https://www.hhs.gov/coronavirus/explaining-operation-warp- speed/index.html (Accessed on November 05, 2020)

Badan Pengawas Obat dan Makanan. Informatorium Obat Modern Asli Indonesia (OMAI) di masa pandemic Covid-19. 2020

Badan Pengawas Obat dan Makanan. Buku Saku Suplemen Kesehatan untuk Memelihara Daya Tahan Tubuh dalam Menghadapi COVID-19. 2020

Isra, M., Bisnu, K. H., Kepel, B. J., & Mulyadi. (2017). HUBUNGAN DUKUNGAN KELUARGA DENGAN DERAJAT HIPERTENSI PADA PASIEN HIPERTENSI Di PUSKESMAS RANOMUUT KOTA MANADO. E-Journal Keperawatan (E-KP) Volume, 5(1).

Kurniawan, H. (2015). Dokter Di Layanan Primer Dengan Pendekatan Kedokteran Keluarga Dalam Sistem Pelayanan Kesehatan. Jurnal Kedokteran Syiah Kuala, 15(2), 114–119.




DOI: https://doi.org/10.18860/jrce.v4i1.15793

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Siti Maimunah

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.